Schwab Charles Investment Management Inc. boosted its stake in shares of Genesis Healthcare, Inc. (NYSE:GEN) by 0.6% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 105,432 shares of the company’s stock after buying an additional 646 shares during the period. Schwab Charles Investment Management Inc. owned approximately 0.11% of Genesis Healthcare worth $184,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Renaissance Technologies LLC boosted its stake in Genesis Healthcare by 116.3% during the 1st quarter. Renaissance Technologies LLC now owns 687,000 shares of the company’s stock valued at $1,814,000 after purchasing an additional 369,400 shares during the last quarter. California Public Employees Retirement System boosted its stake in Genesis Healthcare by 12.5% during the 1st quarter. California Public Employees Retirement System now owns 262,500 shares of the company’s stock valued at $693,000 after purchasing an additional 29,100 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in Genesis Healthcare by 2.4% during the 1st quarter. Bank of New York Mellon Corp now owns 229,770 shares of the company’s stock valued at $607,000 after purchasing an additional 5,451 shares during the last quarter. TIAA CREF Investment Management LLC boosted its stake in Genesis Healthcare by 50.1% during the 1st quarter. TIAA CREF Investment Management LLC now owns 223,085 shares of the company’s stock valued at $589,000 after purchasing an additional 74,502 shares during the last quarter. Finally, Goldman Sachs Group Inc. boosted its stake in Genesis Healthcare by 201.7% during the 1st quarter. Goldman Sachs Group Inc. now owns 85,362 shares of the company’s stock valued at $225,000 after purchasing an additional 57,065 shares during the last quarter. 15.71% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY WARNING: This piece was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this piece on another domain, it was illegally stolen and republished in violation of United States & international trademark and copyright legislation. The correct version of this piece can be accessed at https://www.watchlistnews.com/schwab-charles-investment-management-inc-has-184000-position-in-genesis-healthcare-inc-gen/1701492.html.

Separately, Royal Bank Of Canada reiterated a “hold” rating and set a $2.00 target price on shares of Genesis Healthcare in a research note on Wednesday, September 13th.

Shares of Genesis Healthcare, Inc. (NYSE GEN) opened at $0.93 on Tuesday. Genesis Healthcare, Inc. has a 52 week low of $0.84 and a 52 week high of $4.75. The company has a debt-to-equity ratio of -0.22, a current ratio of 0.18 and a quick ratio of 0.18.

Genesis Healthcare Company Profile

Genesis Healthcare, Inc is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services.

Want to see what other hedge funds are holding GEN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genesis Healthcare, Inc. (NYSE:GEN).

Institutional Ownership by Quarter for Genesis Healthcare (NYSE:GEN)

Receive News & Ratings for Genesis Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.